SMOLDERING MULTIPLE MYELOMA
Clinical trials for SMOLDERING MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug trial aims to stop precancer from turning into cancer
Prevention CompletedThis study tested whether denosumab, a medication that strengthens bones, could reduce the risk of smoldering multiple myeloma progressing to active multiple myeloma. Twenty patients with this precancerous condition received monthly injections for one year. Researchers monitored …
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC
-
New scans aim to predict deadly blood cancer before it strikes
Knowledge-focused CompletedThis study aimed to see if new types of medical scans could better detect when early, pre-cancerous blood conditions progress to full multiple myeloma, a serious blood cancer. Researchers compared three different imaging techniques in 31 people diagnosed with either the early con…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Researchers dig into medical records to map the hidden path of a silent blood cancer
Knowledge-focused CompletedThis study looked back at the medical records of 431 people diagnosed with smoldering multiple myeloma, a pre-cancerous blood condition. The goal was to understand how the disease behaves in real life, identify which patients are at higher risk of it turning into active cancer, a…
Matched conditions: SMOLDERING MULTIPLE MYELOMA
Sponsor: Janssen-Cilag Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC